Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122

SIMPLE SUMMARY: Targeting epigenetic alterations in hepatocellular carcinoma (HCC) provides therapeutic options in addition to traditional treatments. The aim of our study was to evaluate the potential of targeting histone methyltransferase G9a in the development of a therapeutic target. We confirme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Lan-Ting, Lee, Wei-Jiunn, Yang, Yi-Chieh, Chen, Bo-Rong, Yang, Ching-Yao, Chen, Min-Wei, Chen, Ji-Qing, Hsiao, Michael, Chien, Ming-Hsien, Hua, Kuo-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157135/
https://www.ncbi.nlm.nih.gov/pubmed/34069116
http://dx.doi.org/10.3390/cancers13102376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157135/
https://www.ncbi.nlm.nih.gov/pubmed/34069116
http://dx.doi.org/10.3390/cancers13102376

Ejemplares similares